mtm laboratories raises EUR 22 million in Series C financing

13-Oct-2006

mtm laboratories announced that it has raised EUR22 million in a Series C financing from a consortium of existing and new investors. Proceeds from this financing will enable the Company to fund the clinical development and commercialization of its proprietary diagnostic and screening devices in the field of cervical cancer.

The funding round was led by HBM BioVentures and HBM BioCapital, with a consortium which includes Heidelberg Innovation and Wellington Partners together with the new investors Nexus Medical Partners (Boston) and SwissFirst Bank (Zurich).

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...